IL43499A - Process for the fractionation of crude urogastrone and new beta-and-gamma-urogastrones - Google Patents
Process for the fractionation of crude urogastrone and new beta-and-gamma-urogastronesInfo
- Publication number
- IL43499A IL43499A IL43499A IL4349973A IL43499A IL 43499 A IL43499 A IL 43499A IL 43499 A IL43499 A IL 43499A IL 4349973 A IL4349973 A IL 4349973A IL 43499 A IL43499 A IL 43499A
- Authority
- IL
- Israel
- Prior art keywords
- urogastrone
- column
- buffer
- molar
- composition
- Prior art date
Links
- 101800003838 Epidermal growth factor Proteins 0.000 title claims 10
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 title claims 10
- 102000009024 Epidermal Growth Factor Human genes 0.000 title claims 8
- 238000000034 method Methods 0.000 title claims 8
- 238000005194 fractionation Methods 0.000 title claims 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 18
- 239000000463 material Substances 0.000 claims 15
- 239000000203 mixture Substances 0.000 claims 11
- 239000012062 aqueous buffer Substances 0.000 claims 7
- 230000004071 biological effect Effects 0.000 claims 7
- 239000000872 buffer Substances 0.000 claims 7
- 239000000243 solution Substances 0.000 claims 5
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 4
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims 4
- 239000004472 Lysine Substances 0.000 claims 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims 4
- 239000001768 carboxy methyl cellulose Substances 0.000 claims 4
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims 4
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims 4
- 238000001962 electrophoresis Methods 0.000 claims 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims 4
- 229920002401 polyacrylamide Polymers 0.000 claims 4
- 229920001184 polypeptide Polymers 0.000 claims 4
- 102000004196 processed proteins & peptides Human genes 0.000 claims 4
- 108090000765 processed proteins & peptides Proteins 0.000 claims 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 4
- 230000002378 acidificating effect Effects 0.000 claims 3
- 239000004480 active ingredient Substances 0.000 claims 3
- 239000007853 buffer solution Substances 0.000 claims 3
- 230000000694 effects Effects 0.000 claims 3
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 claims 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims 2
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 claims 2
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 claims 2
- 239000005695 Ammonium acetate Substances 0.000 claims 2
- 239000004475 Arginine Substances 0.000 claims 2
- 102400001368 Epidermal growth factor Human genes 0.000 claims 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims 2
- 239000004471 Glycine Substances 0.000 claims 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims 2
- 241001465754 Metazoa Species 0.000 claims 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims 2
- 239000007983 Tris buffer Substances 0.000 claims 2
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims 2
- 239000011149 active material Substances 0.000 claims 2
- 235000004279 alanine Nutrition 0.000 claims 2
- 235000001014 amino acid Nutrition 0.000 claims 2
- 229940024606 amino acid Drugs 0.000 claims 2
- 150000001413 amino acids Chemical class 0.000 claims 2
- 235000019257 ammonium acetate Nutrition 0.000 claims 2
- 229940043376 ammonium acetate Drugs 0.000 claims 2
- 238000004458 analytical method Methods 0.000 claims 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims 2
- 235000003704 aspartic acid Nutrition 0.000 claims 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims 2
- UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 claims 2
- 229920002678 cellulose Polymers 0.000 claims 2
- 239000001913 cellulose Substances 0.000 claims 2
- 235000018417 cysteine Nutrition 0.000 claims 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims 2
- 239000003085 diluting agent Substances 0.000 claims 2
- 235000019253 formic acid Nutrition 0.000 claims 2
- 238000001502 gel electrophoresis Methods 0.000 claims 2
- 235000013922 glutamic acid Nutrition 0.000 claims 2
- 239000004220 glutamic acid Substances 0.000 claims 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims 2
- 229960000310 isoleucine Drugs 0.000 claims 2
- 229930182817 methionine Natural products 0.000 claims 2
- 238000004816 paper chromatography Methods 0.000 claims 2
- 230000000704 physical effect Effects 0.000 claims 2
- GAPYKZAARZMMGP-UHFFFAOYSA-N pyridin-1-ium;acetate Chemical compound CC(O)=O.C1=CC=NC=C1 GAPYKZAARZMMGP-UHFFFAOYSA-N 0.000 claims 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims 2
- 239000000725 suspension Substances 0.000 claims 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims 2
- 239000004474 valine Substances 0.000 claims 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 238000004090 dissolution Methods 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 210000004051 gastric juice Anatomy 0.000 claims 1
- 238000001802 infusion Methods 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 229940102223 injectable solution Drugs 0.000 claims 1
- 229940102213 injectable suspension Drugs 0.000 claims 1
- 238000002347 injection Methods 0.000 claims 1
- 239000007924 injection Substances 0.000 claims 1
- 238000007911 parenteral administration Methods 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 230000028327 secretion Effects 0.000 claims 1
- 239000001632 sodium acetate Substances 0.000 claims 1
- 235000017281 sodium acetate Nutrition 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/485—Epidermal growth factor [EGF], i.e. urogastrone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/834—Urine; urinary system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB5508972A GB1394846A (en) | 1972-11-29 | 1972-11-29 | Polypeptides |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL43499A0 IL43499A0 (en) | 1974-01-14 |
| IL43499A true IL43499A (en) | 1976-05-31 |
Family
ID=10472925
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL43499A IL43499A (en) | 1972-11-29 | 1973-10-28 | Process for the fractionation of crude urogastrone and new beta-and-gamma-urogastrones |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US3883497A (hu) |
| JP (1) | JPS5930685B2 (hu) |
| AU (1) | AU477190B2 (hu) |
| BE (1) | BE807934A (hu) |
| CH (1) | CH608372A5 (hu) |
| DE (1) | DE2359564C2 (hu) |
| FR (1) | FR2207726B1 (hu) |
| GB (1) | GB1394846A (hu) |
| HU (1) | HU169712B (hu) |
| IL (1) | IL43499A (hu) |
| NL (1) | NL185345C (hu) |
| SE (1) | SE411297B (hu) |
| ZA (1) | ZA738179B (hu) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO783724L (no) * | 1977-11-08 | 1979-05-09 | Genentech Inc | Syntetisk dna samt fremgangsmaate til dets fremstilling |
| JPS58134029A (ja) * | 1982-02-02 | 1983-08-10 | Nippon Chem Res Kk | 胃酸分泌抑制成分の分別採取法 |
| US4764593A (en) * | 1983-04-25 | 1988-08-16 | Amgen Inc. | Manufacture and expression of genes for urogastrone and polypeptide analogs thereof |
| GB8409960D0 (en) * | 1984-04-17 | 1984-05-31 | Searle & Co | Therapeutic method |
| GB8409961D0 (en) * | 1984-04-17 | 1984-05-31 | Searle & Co | Pharmaceutical compositions |
| GB8509448D0 (en) * | 1985-04-12 | 1985-05-15 | Ici Plc | Urogastrone |
| JPS6351583U (hu) * | 1986-09-22 | 1988-04-07 | ||
| US4717717A (en) * | 1986-11-05 | 1988-01-05 | Ethicon, Inc. | Stabilized compositions containing epidermal growth factor |
| US5472702A (en) * | 1987-08-26 | 1995-12-05 | United States Surgical Corporation | Sterilization of growth factors |
| US5226912A (en) * | 1987-08-26 | 1993-07-13 | United States Surgical Corporation | Combined surgical needle-braided suture device |
| US5366081A (en) * | 1987-08-26 | 1994-11-22 | United States Surgical Corporation | Packaged synthetic absorbable surgical elements |
| US5306289A (en) * | 1987-08-26 | 1994-04-26 | United States Surgical Corporation | Braided suture of improved characteristics |
| US5222978A (en) * | 1987-08-26 | 1993-06-29 | United States Surgical Corporation | Packaged synthetic absorbable surgical elements |
| US5359831A (en) * | 1989-08-01 | 1994-11-01 | United States Surgical Corporation | Molded suture retainer |
| US5219998A (en) * | 1990-06-04 | 1993-06-15 | Levin Robert H | Yeast-derived epidermal growth factor |
| US5434135A (en) * | 1990-08-02 | 1995-07-18 | Indu Parikh | Growth factor compositions, preparation and use |
| CA2059245C (en) * | 1991-02-08 | 2004-07-06 | Michael P. Chesterfield | Method and apparatus for calendering and coating/filling sutures |
| US20090192554A1 (en) * | 2008-01-29 | 2009-07-30 | Confluent Surgical, Inc. | Bioabsorbable block copolymer |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2292841A (en) * | 1939-03-11 | 1942-08-11 | Michael Reese Res Foundation | Method of obtaining a therapeutic product for inhibiting gastric motility and secretion |
| US2357103A (en) * | 1942-08-04 | 1944-08-29 | Merck & Co Inc | Preparation of pyrogen-free urogastrone |
-
1972
- 1972-11-29 GB GB5508972A patent/GB1394846A/en not_active Expired
-
1973
- 1973-10-22 ZA ZA738179A patent/ZA738179B/xx unknown
- 1973-10-28 IL IL43499A patent/IL43499A/en unknown
- 1973-10-29 AU AU61951/73A patent/AU477190B2/en not_active Expired
- 1973-10-29 US US410557A patent/US3883497A/en not_active Expired - Lifetime
- 1973-11-13 NL NLAANVRAGE7315504,A patent/NL185345C/xx not_active IP Right Cessation
- 1973-11-27 CH CH1666873A patent/CH608372A5/xx not_active IP Right Cessation
- 1973-11-27 JP JP48132961A patent/JPS5930685B2/ja not_active Expired
- 1973-11-28 BE BE138278A patent/BE807934A/xx not_active IP Right Cessation
- 1973-11-28 FR FR7342349A patent/FR2207726B1/fr not_active Expired
- 1973-11-28 SE SE7316083A patent/SE411297B/sv unknown
- 1973-11-29 HU HUIE598A patent/HU169712B/hu unknown
- 1973-11-29 DE DE2359564A patent/DE2359564C2/de not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| NL185345C (nl) | 1990-03-16 |
| GB1394846A (en) | 1975-05-21 |
| BE807934A (fr) | 1974-05-28 |
| DE2359564A1 (de) | 1974-05-30 |
| US3883497A (en) | 1975-05-13 |
| JPS5930685B2 (ja) | 1984-07-28 |
| SE411297B (sv) | 1979-12-17 |
| AU6195173A (en) | 1975-05-01 |
| FR2207726B1 (hu) | 1978-01-13 |
| NL185345B (nl) | 1989-10-16 |
| DE2359564C2 (de) | 1984-06-14 |
| CH608372A5 (hu) | 1979-01-15 |
| HU169712B (hu) | 1977-02-28 |
| IL43499A0 (en) | 1974-01-14 |
| FR2207726A1 (hu) | 1974-06-21 |
| NL7315504A (hu) | 1974-05-31 |
| AU477190B2 (en) | 1976-10-14 |
| ZA738179B (en) | 1974-09-25 |
| JPS4993516A (hu) | 1974-09-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL43499A (en) | Process for the fractionation of crude urogastrone and new beta-and-gamma-urogastrones | |
| WS | The isolation of a hypertension. | |
| Ebert | Amino acid analysis by HPLC: optimized conditions for chromatography of phenylthiocarbamyl derivatives | |
| FI77877C (fi) | Foerfarande foer framstaellning och rening av human le-formig interferonprotein. | |
| DeLange | Egg White Avidin: I. amino acid composition; sequence of the amino-and carboxyl-terminal cyanogen bromide peptides | |
| Seckinger et al. | Tumor necrosis factor inhibitor: purification, NH2− terminal amino acidsequence and evidence for anti‐inflammatory and immunomodulatory activities | |
| JPH05331071A (ja) | カルシトニン遺伝子関連ペプチド類の凍結乾燥組成物および安定化法 | |
| Rudman et al. | Isolation of two lipolytic pituitary peptides | |
| SU1012786A3 (ru) | Способ получени протеинового комплекса,стимулирующего секрецию инсулина | |
| Block et al. | Amino acids in posterior pituitary protein | |
| Watanabe et al. | Flammulin, an antitumor substance | |
| Yamashita et al. | Further purification and characterization of macromomycin | |
| DE2540544C2 (de) | (1-47)-Urogastron und das entsprechende durch Reduktion der Disulfidbindungen erhältliche Polypeptid, Verfahren zu deren Herstellung und diese Polypeptide enthaltende pharmazeutische Zusammensetzungen | |
| IL96839A (en) | Process for preparing a dried preparation of tumor factor 1 similar to insulin | |
| US4347242A (en) | Hypocalcaemic peptides and process for their manufacture | |
| KR860008270A (ko) | α-인터페론의 제조 및 정제 방법 | |
| Lin et al. | Interferon-β-1b (Betaseron®): A model for hydrophobic therapeutic proteins | |
| US4035485A (en) | Polypeptides | |
| CA1340269C (en) | Homogeneous dimeric m-csf and storage stable formulations thereof | |
| USRE32347E (en) | Hypocalcaemic peptides and process for their manufacture | |
| Tamura-Takahashi et al. | Purification and properties of four biologically active components of whale luteinizing hormone | |
| Davy et al. | Chemical differences between thyrotropin isohormones. | |
| GB2056993A (en) | Anorexogenic substance | |
| JP2982078B2 (ja) | イヌ上皮細胞成長因子、該イヌ上皮細胞成長因子を有効成分とする抗炎症剤又は化粧料、及び該イヌ上皮細胞成長因子ｃＥＧＦの製造方法 | |
| White et al. | STUDIES ON ADRENOCORTICOTROPIN. XIII. THE ISOLATION OF TWO HIGHLY ACTIVE BOVINE TYPES |